Trilogy Writing and Consulting Logo

Glossary Terms

Post-submission study

(Also called Phase IV study); a study to delineate additional information about the drug’s risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. (CDISC v 9.0)

Use our tool to look up the definition of terms in our glossary.